A. Sinclair Dunlop sold $1.3M of Apellis Pharmaceuticals (APLS)

Executed Sep 16 2024, disclosed Sep 17 2024, 1 day later.

Value, as filed

$1.3M

37,000 sh across 2 lots

Executed

Sep 16 2024

the trade date, as filed

Disclosed

Sep 17 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AD A. Sinclair Dunlop Director profile →

A. Sinclair Dunlop (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in APLS. The largest single filing was $738K of APLS (31,092 sh × $23.72, as filed), executed Oct 10 2025.

The name

APLS APLS APLS · 32 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by A. Sinclair Dunlop in APLS

APLSSALE Apellis Pharmaceuticals, Inc. $738K
31,092 sh × $23.72
Exec Oct 10 2025
Filed Oct 15 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $702K
31,092 sh × $22.58
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $714K
31,092 sh × $22.95
Exec Sep 19 2025
Filed Sep 19 2025 · 5:30 PM ET